These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. Morgan DJ; McLean AJ Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120 [TBL] [Abstract][Full Text] [Related]
6. Effects of liver disease on pharmacokinetics. An update. Rodighiero V Clin Pharmacokinet; 1999 Nov; 37(5):399-431. PubMed ID: 10589374 [TBL] [Abstract][Full Text] [Related]
7. Protein binding and kinetics of drugs in liver diseases. Blaschke TF Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909 [TBL] [Abstract][Full Text] [Related]
8. Biological determinants of altered pharmacokinetics in the elderly. Shand DG Gerontology; 1982; 28 Suppl 1():8-17. PubMed ID: 7044905 [TBL] [Abstract][Full Text] [Related]
9. Commentary: a physiological approach to hepatic drug clearance. Wilkinson GR; Shand DG Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of pharmacokinetic models of hepatic elimination. Morgan DJ; Smallwood RA Clin Pharmacokinet; 1990 Jan; 18(1):61-76. PubMed ID: 2178850 [TBL] [Abstract][Full Text] [Related]
11. Altered hepatic blood flow and drug disposition. Nies AS; Shand DG; Wilkinson GR Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954 [TBL] [Abstract][Full Text] [Related]